Rapid Therapeutic Science Laboratories, Inc. - FORM 10-K - XML - IDEA: XBRL DOCUMENT - June 17, 2016

Attached files

file filename
EX-32.1 - CERTIFICATION - Rapid Therapeutic Science Laboratories, Inc.pcha_ex321.htm
EX-31.1 - CERTIFICATION - Rapid Therapeutic Science Laboratories, Inc.pcha_ex311.htm
10-K - ANNUAL REPORT - Rapid Therapeutic Science Laboratories, Inc.pcha_10k.htm
v3.5.0.1
Label Element Value
Additional Paid-in capital  
Contributed capital, cash us-gaap_AdjustmentsToAdditionalPaidInCapitalOther $ 49,675
Stock resulting from merger, value us-gaap_StockIssuedDuringPeriodValueAcquisitions $ (210)
Common stock  
Stock resulting from merger, shares us-gaap_StockIssuedDuringPeriodSharesAcquisitions 210,000
Stock resulting from merger, value us-gaap_StockIssuedDuringPeriodValueAcquisitions $ 210
Stock issued to founder, value us-gaap_StockIssuedDuringPeriodValueNewIssues $ 2,500
Stock issued to founder, shares us-gaap_StockIssuedDuringPeriodSharesNewIssues 2,500,000
Accumulated Deficit  
Net loss for the period us-gaap_ProfitLoss $ (10,184)
Stockholders' Equity  
Contributed capital, cash us-gaap_AdjustmentsToAdditionalPaidInCapitalOther 49,675
Stock issued to founder, value us-gaap_StockIssuedDuringPeriodValueNewIssues 2,500
Net loss for the period us-gaap_ProfitLoss $ (10,184)

Rapid Therapeutic Science Laboratories, Inc. Reports